Mike Rona walked in, looked at the board for a moment, and said, “That’s horse shit.”

He was right, and the memory is worth sharing because of the specific way he was right. The diagram was accurate on its own terms. Every arrow was defensible. It was also wrong, because I had built it without the larger picture in the room: without the people whose work it described, without the parts of the system I could not see from where I stood. All that color was the most rigorous possible version of a small view. He did not hand me the answer. He named the thing I could not see because I was too close to my own analysis. That is a special kind of help, and it has a name.

There is a real difference between a mentor and a coach, and it is not a matter of vocabulary. The cleanest version I know comes from Seehusen and his colleagues, writing in Family Medicine: a mentor talks with you, a coach talks to you. A mentor lends you experience. They have walked your terrain, and they tell you what they learned walking it. A coach does something else entirely. A coach does not need to have walked your terrain at all. Their work is to see your walk clearly, to ask the question you cannot ask yourself, and to hold up the part of your own thinking you have stopped examining.

The distinction tracks a change that every clinician who moves into leadership eventually meets. Early on, you lead because you know more than anyone in the room, and developing other people looks like giving them good advice. Later, if you are willing, leading stops being about what you know and starts being about who you are, and developing other people stops being advice and becomes the harder work of asking rather than telling. Mentoring can transmit experience. Only coaching can change an identity. One reason so many leadership programs disappoint is that they teach skills without touching the identity underneath, and a skill laid over an unchanged identity does not hold.

Physicians are especially prone to the trap. Clinical training builds an expert identity so deep it becomes the water we swim in, and setting it down long enough to grow a second one runs against everything the training rewarded. That is not a failure of the accomplished clinician; it is the cost of how good the training is at making us who we are. I felt it as much as anyone. An anesthesiologist’s whole craft is control and vigilance, and I gave up neither easily.

One thing before going on, because the distinction belongs to everyone and not only to the people climbing toward a title. Some of the best clinicians I know were offered the administrative seat and turned it down on purpose, and they were right to. The coach who helps a veteran nurse see her own teaching more clearly, the mentor who steadies a physician through the hardest stretch of a bedside career, is doing the same work to the same end, with no crossing required. This is not an argument that the rooms upstairs are where the better work happens. It is an argument about how people grow, wherever they have chosen to stand.

Here is where it goes wrong in practice. Medicine is generous with mentoring and stingy with everything else. We pair the young clinician with a senior one, we hand out advice, and we call the development done. What we produce is a generation of leaders who are well-advised and under-coached, fluent in what they already knew and unchanged in how they lead. They have been told a great deal and asked very little.

When I say a coach does not need to know your clinical world, the objection comes fast, and it deserves to be reckoned with. The strongest form is not “I don’t need help.” It is that domain expertise is load-bearing, that someone who has never run an operating room, never carried the liability, never lost the patient cannot tell the universal leadership challenge apart from the one specific to your world. That argument is real, and it is correct about mentoring. You do want a mentor who has walked your terrain.

It is not correct about coaching, and the cleanest proof was written by a surgeon. Atul Gawande, at the height of his career and with his complication rates plateaued, hired a retired surgeon to watch him operate and tell him what he saw. The coach held no expertise in Gawande’s subspecialty. After one twenty-minute conversation, Gawande wrote that it gave him “more to consider and work on than I’d had in the past five years,” and he credited the coaching with the gains that followed. The coach could not have done the operation. He could see the operation. That is the entire distinction, demonstrated by a surgeon at the top of his field. You need a mentor who has walked your terrain and a coach who can see your walk clearly. Confusing the two is what produces the reflexive “I don’t need that.”

What made Mike Rona rare is that he was both, and he knew which one I needed in a given moment. He came into my world as a coach: a formal engagement, external, built entirely on questions. Over the years the relationship outgrew its own category. He began to bring his own arc to bear on mine. He had run Virginia Mason, the health system best known for bringing the Toyota Production System into American medicine, and he had seen the same crossing from the clinical world into the executive one that I was trying to make. The coach became a mentor without ever ceasing to be a coach, and he changed the direction of my career more than once. He was the one who taught me that a leader is given only a handful of moments to stand up and beat a shoe on the table, and that the gesture works precisely because it is rare enough to silence the room, and because you spend it only on the values you will not compromise. The next time such a moment arrived, I knew it for what it was, and I stood. Most people give you one or the other; the rare ones give you both, and can tell, in the moment, which the situation calls for. There is a third role past these two, the sponsor, who advocates for you in the room you are not in, but that is its own piece.

Which raises the question every leader eventually answers, on purpose or by default: what do you owe the people coming up behind you? Liz Wiseman’s work on multipliers and diminishers found that the most damaging diminishers are rarely the tyrants. They are the brilliant, well-meaning leaders who step in too soon, who take the problem back because they can solve it faster, who fill the room so completely that the people in it stop growing. The senior clinician who is too expert to make space is diminishing the people around him and would be the last to believe it. Declining the developmental work does not shrink a leader’s influence. It makes it unconscious and undirected.

So I try to do it on purpose. I convene a forum of our clinical leaders that is, by design, a coaching room: a standing space where the people carrying clinical leadership across our sites bring the problems they are actually carrying, and we work them together instead of my handing down answers.

Consider one of the most common things a clinical leader walks in with: an unexpected change in the leadership above them. The administrator they reported to, the one who knew their program and its history, is gone, and the person stepping into that seat is, for now, a stranger. It is a destabilizing thing to absorb, and it happens all the time. The instinct is to bring it to me for the answer. The more useful move is to put it in front of the room, where someone has almost always navigated the same change and can ask the questions the leader is too rattled to ask themselves: what does the new leader actually need from you in the first ninety days, what in your program is now yours to protect, what reads as loyalty to the old regime that you can no longer afford. That is coaching, and it belongs to the room. Afterward, often, there is a quieter conversation in a hallway or on a call, where what the person needs is no longer a question but the steadying weight of someone who has stood in exactly that spot. That is mentoring, and it belongs to one person who has walked the terrain.

I built the forum in part because of Mike Rona. He gave one version of that to me across a table; the forum is my attempt to build a room that does it for many at once. I have said in rooms like it that we know we have succeeded when the people we develop are ready to put us out of a job, and I mean it, even on the days it costs me something to mean it.

Writing alongside Tracy Young a few weeks ago, I said that the leaders who make these transitions possible are the ones who surround themselves with people who are better, brighter, and carry more potential than they do, and then do not stop there but relentlessly develop the crap out of them. I believe it more the longer I do this work. Mike Rona ran a major health system, and then gave the next chapter of his career to developing clinician-executives one whiteboard at a time. That is what the obligation looks like when a person takes it seriously. He could have told me the answer that afternoon. Instead he told me my beautiful diagram was horse shit, and waited for me to see why.

Past the Door publishes free pieces every Sunday. If this one was useful, forwarding it to a colleague who is working through any of this is the best endorsement.

Subscribe now

Twenty-six pages of paper, bound with a binder clip — that was my first privilege application, near the end of residency. Each page had blanks, dozens of them, and some asked about things I had never had reason to think about before: malpractice history. Prior privilege restrictions. Conditions that might affect my ability to practice. I filled in what I could, submitted the packet, and waited for a letter. What I understood about the room where the decision would be made was essentially nothing.

The packet runs longer now — mostly electronic, which makes it more navigable but no less foreign on first encounter. What has not changed is the opacity: you submit, you wait, a letter arrives.

Most clinicians who pass through the process do so from the applicant side only — and a long, serious clinical career can be built entirely from that vantage point. I have sat on both sides of that table. This piece is about what the second side looks like.

Fifteen years after that first application, I sat in the room where those packets are reviewed, vetted, and occasionally debated in ways the applicant will never learn about. What the applicant side had not prepared me for — and what it never quite prepares the clinician who eventually crosses that table — is how often the tension in the room is not about qualifications. Every month there is at least one scenario where a facility’s coverage need, a new service line, or a rushed application sits directly across the table from a file that is not clean. The space between what the institution needs and what is in that file can draw tight enough that a slow exhale from somewhere at the table reverberates like a plucked string.

There is a distinction that every credentialing packet papers over, and that most clinicians never encounter until they are in the room making the decision rather than waiting for it. Credentials and privileges are not the same thing.

Credentials confirm what you are. Board-certified. Licensed. Trained. The background verification that establishes you as a qualified practitioner in your field.

Privileges grant what you may do at a facility. Specific procedures. Specific patient populations. Specific settings within this institution. The authority to perform a right hepatectomy, place an arterial line, or admit patients is not conferred by your certificate. It is conferred by this committee, at this institution, in this meeting.

The committee can credential you and decline your privilege request. It can grant privileges for some procedures and withhold them for others — not because you are unqualified by training, but because the institution does not need you doing them, because the service line structure does not accommodate them, or because the complications they generate exceed what the institution can currently support. The privilege, unlike the credential, is the institution’s act. It can be withheld, restricted, or revoked for reasons your residency or training program never taught you to anticipate.

Clinicians applying for privileges typically arrive assuming the committee is reviewing their training. What the committee is actually reviewing is considerably more complicated. That review looks backward — case logs, incident history, a prior institution’s adverse action record — and forward: coverage needs, service line strategy, an institutional plan the applicant has never seen and was not required to consult.

The formal mandate of the credentialing committee is the verification of qualifications and assurance of clinical competence: the mechanism through which the institution protects the patients it serves. Every piece of documentation, every attestation, every primary source verification requirement that flows from TJC Medical Staff standards is oriented toward a single claim: the institution will only grant clinical authority to practitioners whose qualifications have been verified and whose competence is reasonably assured. This is a protection for the community served, and one that by design is managed by the medical staff itself.

That mandate is real. The National Practitioner Data Bank query, mandatory for every initial credentialing and every two-year recredentialing cycle, surfaces adverse actions, malpractice payments, and privilege restrictions at prior institutions. References are contacted in most institutions, and they often matter more than they appear to: a hedge from a reference of the applicant’s choosing is reason to look harder; an outright negative from that same reference is a major red flag. Peer review records from within the institution, where they exist, are available to the committee. Records from prior institutions are rarely available in practice. Protection statutes prevent compelled disclosure, and voluntary disclosure is inconsistent. The focused professional practice evaluation period (FPPE) that follows most initial privilege grants is a structured mechanism to verify that the granted authority is being exercised as expected.

When the process works as designed, it is an imperfect but genuine instrument for patient protection.

What the formal mandate does not capture is everything else the committee manages simultaneously.

The institution needs overnight call coverage in the cardiac procedural lab. A structural heart program has been in development for eighteen months, and the committee is reviewing a privilege request from the interventional cardiologist expected to anchor it. The service line economics behind that program are not before the committee. The coverage gap it fills is not on the agenda. The relationship between that privilege grant and the institution’s three-year strategic plan is not part of the formal record.

None of that is improper. Institutions have clinical needs. Privilege decisions that serve both quality and coverage objectives are not compromised decisions — they are how the process is supposed to work when it works. The problem is not that coverage needs influence privilege decisions. The problem is that clinicians who encounter this process as applicants have no window into it, and clinicians who cross to the other side of the table for the first time are often surprised by how much organizational intelligence the room contains that the formal mandate never names.

In the rooms I have sat in, the political overlay is visible before the quality discussion begins, even when it goes unnamed.

Some of it is overt. Two competing cardiology practices on the same medical staff is not unusual, and when an application comes before the committee from a cardiologist who would practice in that same market, the political pressure rarely arrives as stated opposition. It arrives as calibrated scrutiny: volume thresholds that no one examined closely for the previous three applications, FPPE parameters that run longer than the standard, pointed questions about outcomes at the prior institution. Committee members with referral relationships to the established groups may not even recognize the degree to which those relationships are shaping their reading of the file. A well-run committee can name this dynamic when it sees it, precisely because it is tied to a recognizable interest and operates in visible enough territory to be interrogated. The distinguishing question is whether the threshold being applied was already in place, or materialized with this application.

The more consequential version involves existing privileges rather than new applications. A neurosurgeon or orthopedic surgeon is on active staff with an unrestricted privilege set — which means, in many institutions, that the privilege form carries no age limit. When a pediatric patient comes through the emergency department with a problem that falls within that specialty, the clinician can be called. Many have not provided meaningful pediatric care since residency or fellowship.

The request that comes before the committee is not for expanded privileges. It is for restriction. The surgeon wants explicit age limits placed on the privilege form — not to gain anything, but because the next call is coming and they do not want to be in that position. The initial reaction around the table is often sympathetic. The argument is reasonable on its face: a clinician who is not current in pediatric care should not be providing pediatric care.

Then someone asks the question that changes the room: what happens when a pediatric patient presents with something that cannot wait — an intracranial hemorrhage or a vascular injury — and the privilege set the committee just amended specifically excludes children? A restriction that protects the clinician from an uncomfortable position creates a care gap that, in a community hospital without a pediatric subspecialty service, could cost a life. That is not hyperbole. I have watched an adult neurosurgeon take a toddler to the operating room within minutes of arrival to the ED for a hematoma evacuation that could not wait for transfer, because a fall from a shopping cart had produced a hemorrhage that was going to kill that child without immediate intervention.

Both paths available to the committee are uncomfortable. Neither is wrong. The committee’s job is to make the choice it can defend against both the clinician’s reasonable concern and the patient’s unanticipated need.

In many committee cultures, the department chair whose support for an application signals acceptability to the rest of the committee carries weight that the written references do not. The committee member who trained at the same institution as the applicant may read the malpractice history differently than the member who did not. The service line leader who has been waiting three years for this privilege grant will move through the FPPE requirements differently than the one whose existing coverage relationships are threatened by the new applicant.

These dynamics do not make the process corrupt. They highlight its humanity. People read the same application through the lens of their own institutional position, their own professional relationships, and their own reading of what the organization needs. The committee’s job is to produce a quality-grounded decision in the presence of those dynamics, not in their absence.

The medical staff leader who understands this is not more cynical about the process. That physician is more useful to it — more able to see when a quality concern is genuine and when it is a quality-framed version of a different concern, and to recognize which situation requires a harder conversation than the room is currently having. In the pediatric coverage example, the harder conversation is not approval or denial. It is whether the privilege can be structured — through a defined scope, or a clear escalation pathway — in a way that acknowledges the gap honestly and builds the protection into the approval itself.

Peer review protection is what most physician executives encounter first and understand last.

When the committee gets a difficult decision wrong — when political pressure overrides a genuine quality concern, or when a legitimate quality concern is being borrowed to cover something else — there is very little external check. The protection that ensures it stays that way is not incidental to the process. It is built into it.

The protection exists for legitimate reasons. Candid clinical review requires confidentiality. If the committee’s deliberations about a privilege concern were fully discoverable, the risk management calculus would suppress exactly the honest discussion the protection is designed to enable. In most states, the deliberations of a credentialing committee, and the documents produced in peer review proceedings that come to the committee for review, are shielded from discovery in civil litigation for precisely this reason. The process producing the most consequential decisions about a clinician’s right to practice is also, by design, one of the least externally transparent processes in institutional governance. When the committee gets it right, that confidentiality serves everyone. When it gets it wrong, the primary accountability is internal. External mechanisms — Joint Commission reviews, state medical board proceedings, and mandatory federal adverse action reporting — can reach the same questions from a different angle, but they operate at a distance and rarely intervene in the committee’s deliberative process itself.

The physician executive who recognizes this asymmetry is better positioned to ask the harder question — not “is this decision defensible?” but “is the quality concern doing the work, or is it being borrowed for a different purpose?”

For the clinician still on the applicant side of this process — which, for many, is the only side they will occupy — the preceding sections are useful context. For the one moving toward the governance seat, they are the starting frame.

What this means for the physician executive is specific. The culture of the committee is largely the committee’s own responsibility to build and maintain, and within the committee, that responsibility sits most heavily with the senior clinical executive in the governance structure: the CMO, Chief of Staff, or VP Medical Affairs, depending on how the institution has organized that authority. That executive is the clinical voice that shapes what questions get asked, how the room holds the discomfort of a file that is not clean, and whether quality remains the actual driver when a difficult decision is on the table. The physician executive who is not in that seat needs to understand what that culture has already built before they can contribute to it — or challenge it. The question of whether quality is the actual driver of a privilege restriction, or whether something else is operating under that label, can only be asked honestly inside the room. It requires institutional credibility and interpersonal directness. And it requires a clear answer to whose interest the process is meant to serve.

The answer is the patient.

The obligations described here belong to the medical staff leader specifically, because the committee room is, structurally, a physician’s room.

What the physician executive owes the credentialing process is not complexity for its own sake. It is two things, held together, that are in tension often enough to deserve naming.

The first is genuine quality protection. When the NPDB query surfaces something significant, the committee’s job is to take it seriously — not to find a path through it because the coverage need is real or the department chair is enthusiastic. When a colleague’s FPPE reveals a pattern, the committee’s job is to address it before extending the privilege, not after. The threshold is patient safety. Everything else is secondary to it.

The second is organizational honesty about the other things the committee is managing. Coverage needs, service line strategy, departmental relationships — these are legitimate institutional concerns that properly shape how privileges are structured and what proctoring arrangements accompany them. The mistake is not that these concerns exist. The mistake is pretending they are not in the room when everyone present can see that they are, or worse, clothing them in quality language they have not earned.

The physician executive who can hold both of those responsibilities simultaneously is doing something that neither a credentialing committee operating as a purely administrative function nor a medical staff organized purely around clinical autonomy can do on its own. That physician executive is translating between the institution’s organizational reality and its quality obligation, in the specific room where those two things have to coexist. The same logic that produced a structured privilege scope in the pediatric example applies to every table conversation where the quality and the organizational concerns are both real.

The clinician who goes through credentialing as an applicant learns that the process has rules. The physician leader who sits on the committee learns that the process has a culture, and that the culture — not the rules — is what determines whether the process actually does what it claims to do.

Building that culture is not a credentials task. It is not a compliance task. It is the exercise of the specific authority the physician executive carries into a room where the institution is making decisions about clinical practice — decisions that reach forward into every patient encounter involving every clinician the committee approves.

That is the work the training did not name. Being clear-eyed about what it requires is where it starts.

Somewhere, right now, a clinician is filling in those blanks and waiting for a letter. What they know about the room where the decision will be made is essentially nothing.

Past the Door publishes free pieces every Sunday and paid pieces every other Friday. If this one was useful, forwarding it to a colleague navigating the executive transition is the best endorsement.

Subscribe now

Most clinicians develop that rhythm around completion rather than comprehension — which is a defensible trade, until it isn’t. The goal is to get through it accurately, sign it, and get back to clinic. That is a reasonable response to a form that is long, repetitive, and asks for information you have already provided to three other credentialing offices. It is also, quietly, the wrong approach.

The reason comes down to what the form is.

The form is not a record-keeping document. It is a legal instrument. What you sign at the end is not an acknowledgment that you have filled in your training history — it is a request for the institution to grant you specific clinical authority. The distinction matters more than it appears, and it matters most in the section most clinicians complete with the least attention.

The most common behavior, across new and experienced applicants alike, is to check everything on the list that falls within their specialty area. The reasoning is intuitive. More privileges means more coverage. An unrequested privilege is a gap in your practice that might create a problem later. If the form offers a box, and the box is within your specialty, there seems to be no cost to checking it.

There is a cost. It is just not visible at application.

The privilege set you request is what the institution authorizes you to perform. It is also what the committee will compare to your case logs at your next recredentialing cycle. If the privileges you hold say you perform a procedure, and your cases from the prior two years do not support that, that discrepancy lives in your record. At renewal, the committee has both the privilege set you asked for and the cases that do or do not reflect that you used it. A gap between the two requires explanation.

Requesting privileges you do not intend to exercise, or that your practice in the prior cycle does not support, is not a hedge against future gaps. It is a paper record that does not match your actual practice, held by an institution that will look at both.

The second consequence of reading the form carelessly is more immediate: what it says defines what you can be asked to do, now, not at renewal.

Privilege forms carry language. A privilege described as applicable to adult and pediatric patients does not become a pediatric privilege only when you want it to be. At many institutions, the privilege structure and call coverage are explicitly connected — call is a standing obligation for active clinical staff unless the medical executive committee removes that obligation for a particular applicant or department. Where that structure applies, a privilege you hold creates real exposure: if a clinical need arises within that scope, your name is in the system as someone credentialed to provide that care, and the institution’s response to that need may include you before you have had any opportunity to revisit what you signed. Clinicians requesting privileges in a given specialty are thinking about the cases they expect to take. Your scope at that institution is whatever the form says, not whatever you intended when you checked the box.

This is not an argument against requesting broad privileges where they are genuinely warranted. It is an argument for knowing what you are requesting. The form tells you. Reading it is the first step in understanding your actual clinical scope at that institution — not in theory, but on paper, in the institution’s records.

The third issue produces the most risk with the least visibility.

The decision about which privileges to request is inherently a clinical judgment. Clinical judgment cannot be delegated to the person submitting the paperwork.

Physicians and advanced practice providers in group and employed settings frequently have their office complete the application on their behalf. An administrator or coordinator fills in the employment history, tracks down the references, and marks the privilege checklist. The clinician reviews, signs, and returns it.

The administrator filling in that form is making selections about clinical authority. They are not doing this carelessly — they are trying to get the application right, working from whatever guidance they have about what the physician typically does. But they are a non-clinician making a legal request for clinical practice privileges at a specific institution, without the clinical context that would allow them to weigh what those privileges mean or what supporting case logs the physician can produce at renewal.

The clinician who signs without reading the privilege section is trusting that someone else accurately characterized their clinical scope and the evidentiary record behind it. That trust is more often misplaced than reasonable — not because administrators are careless, but because the decision is not theirs to make.

You are not filling out paperwork. You are making a specific, documented request for clinical authority at a specific institution, with a record that will follow you through every renewal cycle.

Of all the steps in the credentialing process, the application is the only one the applicant controls. What follows — the review, the deliberation, the decision — happens in a room the applicant never enters. The proportional attention most clinicians give to the part they own versus the part they don’t is almost exactly backwards.

That is where this series goes next. It publishes free Friday as a preview of what paid posts look like. The paid tier opens June 23.

Past the Door publishes free pieces every Sunday. If this one was useful, forwarding it to a colleague who is working through one of these is the best endorsement.

Subscribe now

The people who will live with that number are not in the room. The nurse on that future Tuesday night is not here. Neither is the patient whose call light she will be slower to answer because the floor is one body short. The decision that shapes their evening is being made, reasonably and in good faith, by people who will never meet them.

This is the first thing to understand about healthcare’s closed rooms. They are not sinister. The decisions made in them are rarely malicious and almost never hidden. They are simply closed to the people whose work and lives are shaped most directly by what happens inside them. The teams at the table, often on both sides, have rarely been in a hospital room except as a patient or a visitor.

There is another kind of room entirely. The operating room at three in the morning. The intensive care unit. The recovery floor. These are rooms about the patient, where the most human parts of medicine happen and where the decisions that matter most to a single person get made in real time, by the people standing over the bed. Most of us can enter one kind of room or the other. Almost no one sees both.

I have spent more than two decades moving between them, the clinical rooms and the administrative ones, and I have come to think of the administrative side as seven rooms. Some readers know these rooms perfectly well and have chosen the bedside on purpose; what follows is not an argument that the rooms are where the better work happens, only that what gets decided inside them reaches the bedside whether or not the bedside ever sees the room. Here is the map.

The contracting room

We have just been in the first room. It is worth staying a moment longer, because it shows the pattern the other six repeat. Two things make it consequential. The first is who is absent: the negotiation has a chair for the system and a chair for the payer, and not one for the nurse, the patient, or the clinician whose Tuesday night the number will shape. The second is time. The negotiation itself is often a series of meetings stretched over weeks or months, where a change made at the end can quietly undo something agreed at the beginning, and the gap between the final decision and its effect runs another twelve to eighteen months. By the time the floor feels the squeeze, almost no one traces it back to a number agreed a year and a half earlier in an office park. The decision and its consequence are severed cleanly enough that the room is rarely held to account for either.

The credentialing committee

The second room decides who is allowed to do the work. The physicians already on the medical staff review the files of the physicians, nurse practitioners, and physician assistants who want to join them, and they hold the authority to say yes or no. It is a necessary function and, done well, a careful one; the rigor is the reason the work carries the trust it does. The friction is that the process is structurally slow, gated by primary-source verification and payer enrollment as much as by the committee’s own calendar, and unforgiving of timing. A fully qualified clinician with a clean file can miss a cycle over an administrative detail that has nothing to do with competence, a license that transferred a few days late, a signature that landed after a cutoff. Each name that does not clear in time is a name that is not at the bedside the following month, and in a market already short of clinicians, the cost of that delay falls on the patients who wait and the colleagues who cover the gap. Most patients never picture this room, and it helps determine who is there to care for them.

The executive office

The third room is where workforce planning meets arithmetic. At some point every system runs into the same wall: there are not enough trained clinicians to fill the roles, and the gap is widening as the population ages.

The story most people hear is that fewer young people want clinical careers. The actual problem is closer to the opposite. The binding constraint is training capacity. The 1997 Balanced Budget Act capped the number of Medicare-funded residency positions at roughly their 1996 level, where they stayed essentially frozen for more than two decades until Congress added the first new slots in 2021 and 2023 (AAMC). The pressure shows in the Match: in 2025, more than 47,000 active applicants competed for roughly 40,000 first-year positions, and about 9,500 of them did not match into one (NRMP). On the nursing side, the American Association of Colleges of Nursing reported that schools turned away more than 65,000 qualified applications in 2022 for lack of faculty, clinical training sites, and budget (AACN). That is a different problem than the one most leaders are solving for, and it has different solutions.

The peer review committee

The fourth room is where the clinical and the administrative meet. When a hard case goes to peer review, a physician’s work is examined by colleagues behind a closed door, and the lessons of that case do not stay with the clinician; they become the standard the whole department is held to afterward. A single difficult airway, reviewed honestly, can change the preoperative checklist every colleague follows the next morning. This is clinical governance at the case level, and it is closed for good reasons, including fairness to the clinician and candor in the discussion. It is consequential precisely because the rest of the department inherits whatever the room concludes. There are other rooms like it, the morbidity and mortality conference, the privileging committee, the quality review group that reviews nursing care and medication errors, and I will write about each in time.

The compensation committee

The fifth room is where senior executive pay gets set, and most of the decision is made before anyone sits down. A consultant builds the number over weeks against a hand-picked peer group and a target percentile, and a compensation committee of a few board members, usually with backgrounds in business or finance, meets to ratify it, often in under an hour. The deliberation stays inside the room. Even what eventually becomes public can understate the total, since incentive structures, deferred compensation plans, and other legitimate vehicles reduce what is reportable in a single year. The figure that does surface, for a nonprofit system, sits on a tax form almost no one reads, and only for a handful of the highest-paid executives.

I am not arguing the nonprofit construct is broken. I am arguing it has features that let compensation outrun the mission’s reach into the community, and that the conversation we are not having is about the features themselves. The numbers we can see point at the tension. At twenty-two major nonprofit medical centers, the wage gap between hospital chief executives and registered nurses rose from 23 to 1 in 2005 to 44 to 1 in 2015, while inflation-adjusted nurse pay barely moved (Marcus et al., Clinical Orthopaedics and Related Research), and research on nonprofit systems has found that most of the growth in chief executive pay tracks the size of the organization a leader runs more closely than the quality of the care it delivers (PLOS One). One state-level analysis went further still: a North Carolina report found the 2019 pay of eleven nonprofit hospital chief executives equal to the salaries of 572 registered nurses (NC State Health Plan).

The succession room

The sixth room decides who comes next. The question of who replaces a chief executive when she retires gets answered long before the rest of the organization knows there is a question, and the way it gets answered tells you what a board actually values. I have said in rooms like this one that we are successful when those we develop put us out of a job. That line tends to cool a room, because most leaders still measure success by how long they hold the seat rather than by who they have ready to take it.

The deal room

The seventh room is where a community hospital becomes a chain asset. Mergers and acquisitions are how a great deal of American healthcare is now organized, and the logic of a given deal is usually sound on its own terms. Often it is more than sound; the capital and the capability a larger partner brings are sometimes the only thing that keeps a struggling hospital’s doors open, and I have changed my own mind over the years about how much good the right partnership can do. What the model on the table almost never prices is the local discretion that lets a hospital do something for its community that would never clear a system-wide spreadsheet, along with the slower effects on the credentialing pipeline and the staffing ratios this map has been tracing. Decision rights move upward and outward, toward the standard and away from the floor, and that trade is real whether or not anyone in the room names it. Those effects show up eighteen months after the signing, in rooms the deal room never has to sit in.

The force that runs through all of them

There is an eighth space I have deliberately left off the numbered list, because it does not behave like the others. The rulemaking process, where a federal or state agency sets a payment rule through notice and comment, acts on several of the seven at once. A change to how procedures are paid for reshapes the contracting room and the deal room together. A change to how training is funded reaches straight into the executive office. Regulation is less a room you enter than a current that runs underneath the others, and it moves the water in all of them.

What this map is for

A word on what this is not, because the discipline matters and is worth saying aloud so a reader can hold me to it. This is not a map for gossip. It does not name and blame. It will not trade on outrage to keep your attention, and it will not critique former colleagues or employers in public, because that work belongs in private conversation. What it will do is describe, plainly and specifically, what happens in the rooms most readers never enter, and trace the line from each of them to the bedside, where the consequences land. I will credit the people whose work I respect by name. I will sit with complexity rather than pretend it away. And when I change my mind about something I have argued for here, I will say so and explain why.

The reason to draw the map at all is that the people in the clinical rooms and the people in the system rooms are, more often than either side admits, working toward the same thing and unable to see each other do it. The family in a surgical waiting room cannot see the contracting room that set the staffing on the floor where their father will recover. The board in the compensation committee rarely sees the three-in-the-morning version of the hospital it governs. Almost no one in American healthcare can stand in all seven of these rooms and the clinical ones too, and the cost of that is a system whose halves keep deciding each other’s conditions without ever meeting.

The number agreed in that office park takes effect long after anyone remembers the meeting. The nurse who is one body short on a Tuesday night will not know why, but she will be the first to feel it, and her floor is where a year-and-a-half-old number finally becomes legible as a real night with a real patient. The people who set the conditions she works under will never see that floor at the hour it is hardest. Most of these rooms close before the consequence arrives, and open again before anyone connects the two. The slow work of this newsletter is to connect the decision to the floor it lands on, so that the people in the rooms and the people at the bedside are at least describing the same system.

From the room you can’t see, the voice you need to hear.

Each of the seven rooms gets its own piece. Subscribe at pastthedoor.com to read them as they publish.

By the time we met, the story many people read earlier this month had already happened. The Thursday that felt like a cold. The Friday night his heart, lungs, kidneys, and liver all began to fail. His wife Jordan, three months pregnant, waiting in the hospital parking lot because pandemic protocols wouldn’t let her inside. A ventilator twenty minutes after he walked through the ER doors. A life-flight. A national transplant waiting list. A heart, two days later, from someone whose name he didn’t know.

I met Tristan after. The version I know is the one who came out the other side.

What I have watched, close up, over the years since we became friends, is what someone does with time they weren’t supposed to have. He has spent it building. Earlier this month, he and his team introduced Transplants.org to the world. I have been an advisor for several years. Here is why I said yes, and why I think it matters.

Tristan’s own account is worth reading in his words before or after this one: Tristan's post on LinkedIn

What I can offer is the clinical read on the speed of it.

In Tristan’s case, multi-organ failure didn’t announce itself. A cold on Thursday. By Friday night, four organ systems in crisis. For anyone who works near a hospital, the sentence that lands hardest is this one: ventilated twenty minutes after walking through the ER doors. That is not slow deterioration. That is a body shutting down faster than most people can imagine, in a window measured in hours, not days.

The other sentence worth pausing on is the one about five years of memory loss as the cost of the oxygen deprivation that came with the organ failure. He woke up alive. He woke up missing five years. The heart was a gift. What accompanied it was not.

That is worth sitting with for a few minutes. What the system counts — the transplant, the discharge, the organ function — is not the same as what the patient carries every day after they leave the hospital.

The transplant system Tristan came back into is exceptional at certain things and genuinely inadequate at others.

What it does well: the acute phase. The allocation and procurement process, the surgical care, the transplant coordinators in the immediate post-operative window. The coordination required to move a viable organ from one person’s chest to another’s in a matter of hours is remarkable. We are, as a system, very good at the part that gets you to discharge.

What comes after discharge is a different matter.

Once a transplant happens, immunosuppression is for life. With very rare exception, that medication is taken every day until the recipient dies — stopping it is how the organ is lost. The medication keeps the new organ alive by suppressing the immune system, which creates a constant balancing act: suppress too little and the body rejects the organ, suppress too much and infection becomes the threat. Over years, that same suppression raises the risk of malignancy — post-transplant lymphoproliferative disease and skin cancers among the more serious late concerns. Managing that balance across an ordinary life that includes travel, illness, aging, other medications, and stress is lifelong work. Much of that work, the patient and their family figure out largely on their own.

The questions that come up seem simple at first. Is this symptom rejection, or something else? Who do I call at 11 p.m.? What does the new doctor who didn’t do my transplant need to know? The transplant center is built for the acute phase. Over time, for many patients, it becomes harder to reach, and the answers get harder to find.

Transplants.org was built for what comes after.

It is a nonprofit focused on the full arc of the transplant journey: from first consideration through the listing process, through recovery, and through the decades of lifelong management that follow. In practice, that means resources for the patient navigating immunosuppression in year four, for the family that doesn’t know which doctor to call at midnight, for the primary care physician who took on a transplant patient without ever having trained for it. It is not affiliated with a specific hospital or transplant center. That independence matters. It lets the organization follow the patient rather than the institution.

Medical advisors from Mayo Clinic, Cleveland Clinic, Vanderbilt, UCLA, and Duke. Policy advisors with federal health legislation experience. Oracle and United Therapeutics as organizational supporters from the beginning.

My stake in this is worth naming. I have been an advisor to Transplants.org for several years. Tristan and Jordan are close personal friends. I have no equity in the organization and no financial relationship with it. I am writing this because the mission is right and the team is real, and because I have watched the work closely enough to believe both of those things.

What I bring to the advisory role is a clinical view of what the post-transplant journey looks like from the care side. My specific clinical expertise is in liver transplantation. I have some sense of what patients and families carry out of the hospital when the acute phase is over.

Tristan uses the phrase “bonus time.” It appears in the post he published earlier this month, and I have heard him use it before.

Most people who survive what he survived are grateful. Most go on to live well. A smaller number feel the pull to do something with the life they were given back. Tristan is doing something that most people, even those who feel that pull, do not do: he is building an organization for the next person in that ICU bed.

The question that comes with watching that, at least for me, is not a comfortable one. Why does it take a heart transplant recipient to build this? What does it say about the system that this organization did not already exist?

I have a partial answer. Medicine trains clinicians to deliver care within existing institutions, not to build the ones that don’t yet exist. The knowledge and the instinct to close a gap like this can accumulate over a clinical career. The capacity to act on it — the time, the access to capital, the freedom to move without institutional approval — almost never does. Tristan came back to his life with something unusual: a mission that required no organizational permission to pursue. That is an uncomfortable thing to say about a field that otherwise works hard at developing its people.

What Tristan built sits in that space — outside the institution, accountable only to the patient.

Visit Transplants.org. If you know a patient or a family navigating the transplant journey, send them there. If you are a clinician working in transplant medicine or adjacent to it, follow the work.

I met Tristan after the transplant. What I have watched since is someone doing something uncommon with the time he has. It is worth paying attention to.

Tracy Young is the co-founder and Chief Operating Officer of Essential Anesthesia Management and a practicing CRNA. He has been on every side of the clinical-executive translation question in this organization. We wrote our sections separately and edited each other's. The conversation was worth having in both directions at once.

The first formal feedback I received as a new executive came at a small, round, four-person table in the corner of a very typical executive office. Dark wood furniture, a desk and table both carrying stacks of papers and file folders, the printout of a PowerPoint deck for the upcoming board meeting laid out in front of the CEO and the COO. I had presented to the Executive Team from that deck the day before. I had walked into the meeting expecting we would talk about the substance of what I had presented. We did not, at least not in the way I expected.

The feedback was not about a decision I had made. It was not about the substance of the deck. It wasn’t about my expertise as the physician executive on the team. It was about how I was showing up in the room. The CEO told me, specifically and warmly, that I needed to slow down. That I needed to strip the technical expertise from my lexicon and my presentation style. That the rest of the senior team and the board needed the space and the time to ingest what I was sharing, sit with it, ask questions, and land on a good decision themselves. The COO did not say much, but she did not need to. She was nodding at the right beats, and I could read in the rhythm of her agreement that this was a conversation the two of them had decided was worth having before it got harder to have.

What I remember as clearly as the words themselves is the feeling of the conversation. This was not criticism. This was the first round of honest, direct feedback from someone who had decided, before I walked in, that the incorporation of it was critical to my success and growth as an executive, and that the same incorporation would bring benefits to the organization as a whole. The two were not in tension. They were the same investment, made twice. I had spent the twenty years before that conversation training to be the most prepared person in the room. The CEO was telling me, in the most generous way he knew how, that I had taken a job that called for a different skill set. A different way of showing up.

That conversation has stayed with me for the better part of a decade. Almost every time I have watched a clinician make the move into administration since, I have recognized a version of the same gap. The version I lived was about cadence and language. For someone else, it might be how meetings get run, or how decisions get framed, or how disagreement gets handled. The shape underneath each of these scenarios is the same. Clinical training rewards being the answer. Executive work, especially across a senior team, is about creating and holding the space that makes the answer-finding system work.

I’d argue that this is the single most important reframe a clinician moving into administration has to make, and the one most clinicians moving into administration miss for longer than they should. At the bedside, expertise is the asset. The patient in front of me benefits from the fact that the clinical team around them has read more, trained more, and seen more of this specific clinical scenario than almost anyone they will encounter on the worst day of their life. In the C-suite, expertise is one of fifteen things in the room, and rarely the most important one. The job is to lead a body of work in which I am the second, fifth, or tenth most expert voice about almost any given decision. The Chief Operating Officer knows the operations better than I do. The Chief Financial Officer knows the economics better than I do. The Chief Development Officer knows the pipeline better than I do. My job is to make sure the right clinical reality is in the room, in language the rest of the team can act on, before they make a decision that will live or die at the bedside.

When I have not done that well — and I have not done it well plenty of times — the failure mode is recognizable. I show up too prepared. I anchor the room early. I leave too little oxygen for the operators and finance leaders to bring their own constraints into the picture. The decision the room reaches is technically correct and operationally fragile at the same time. We end up implementing something the front-line clinicians cannot actually execute, and three months later we are doing the work over again from a worse starting place. Slowing down, stripping the lexicon, and making space turns out to be more than a presentation note. It is the actual mechanism by which a senior team makes good decisions together.

Once a clinician learns to stop showing up as the answer, the question that takes its place is a different one. Not “what should we do,” but “what is the room actually missing that I am uniquely positioned to bring.” The honest answer to that, in my experience, is rarely the technical knowledge the team assumed they were getting when they hired the clinician.

The job most clinicians think they are taking and the job they have actually taken are not the same job. Most assume the role is, at its core, the clinical voice in the C-suite. That description is not wrong. It is incomplete. The function of the job is the translator role, and the translator role is the load-bearing wall of the seat.

What I mean specifically is this: if I cannot carry a clinical concern to a non-clinical COO in language she can act on — meaning she understands the operational shape, the financial implication, the workforce signal, and the decision she is being asked to make — I have not done my job, no matter how well I have understood the clinical concern myself. Conversely, if I cannot bring an operational reality back to a clinical lead in language he can act on — meaning he understands why a contract distinction changes how the OR director feels about a six o’clock Friday case, or why a payer mix affects which staffing model is sustainable at his site — I have not done that job either. The clinical voice in the room does not stop at telling the truth about the clinical work. It keeps going, into making the truth usable to people who do not live inside that work day to day.

One of the clearest examples I can recall sat at the intersection of ability to pay and non-emergent but life-saving care. Cancer treatment, transplant work, the kinds of cases where insurance coverage shapes whether a patient has a path forward. For several rounds in that conversation I did not create enough space to hold the real question the organization was sitting on. The clinical team was carrying the moral injury of saying no, or watching the system say no on their behalf, to patients who did not have a financial path to long-term management of their care. The no-margin-no-mission line everyone in the room had already absorbed was real and unmoving. The conversation kept landing in one of those two corners and breaking against it.

The translator move I eventually learned was not to choose a corner. It was to hold the room long enough for the finance team and the clinical team to land somewhere together — a place where the conversation shifted from whether the organization could afford to say yes to how a conditional yes could be structured: what the program could commit to upfront, what the patient could demonstrate over time, and where the clinical and financial risk would sit between those two realities. The lead message to a patient could be options rather than a no, and patient autonomy could carry the weight of the decision. That message did not exist in the room before someone created the space for it. The seat I was in was the seat that was supposed to do that work.

The last one took me the longest to see clearly, and I think it is the one most clinicians moving into administration handle without ever putting language to it. It is the question of what to do with the clinical practice itself. I still pick up a few clinical shifts a month. I do that because the patient interactions ground me, because the teams I work alongside on those days are one of the strongest reminders I have of what we are building EAM around, and because the clinical specifics keep me current in a way that helps me lead the company. Those shifts are additive. They make me better at the executive work, not worse.

I have also watched clinicians in administrative roles hold onto a clinical practice for a different reason. The executive role feels uncomfortable. The clinical role feels familiar. The hours in clinic or in the OR become a way to recover the identity that the new seat is asking them to reshape. That is the protective version of the same arrangement, and it does not announce itself as protective at the time. It looks like commitment. It looks like staying connected to the work. The candid take on it usually requires someone outside the situation to label it, and the person hearing it named almost always pushes back the first time, because the protective version of the practice is doing real psychological work for the clinician holding onto it. What it is doing, specifically, is grieving. Or, in the language I tend to use, holding onto something the move into the executive seat carries a real fear of losing. Standing in the clinical hierarchy, the rhythm of being known by what your hands do, the patients themselves. Those losses are real, and they are not small. The protective version is the version that has not figured out how to live with the loss yet.

I am not arguing that clinicians in executive roles need to give up their practice. I am arguing that clinicians in executive roles need to be honest with themselves about which version they are running. I’m saying out loud that the job requires a certain amount of straddling the fence between the two worlds, but in a way that recognizes and capitalizes on that position. And I am arguing that the leaders who hold the development relationships inside those organizations — the CEOs, the co-founders, the senior executives who have made the transition and remember what it cost them — need to make it safe to have that conversation out loud, so that the protective version can become additive or fall away.

You and I came at this seat from opposite ends of the same problem. You built up through the firm — a clinician who became the operational executive, then a co-founder, then a partner who has been on every side of the clinical-executive translation conversation in this organization. I came in from outside it, after twenty years of clinical practice and fifteen of executive work in large health systems where the seats and the systems looked very different from the one we are running together now. The thing we agree on, before any of the rest, is that clinical training does not prepare a person for what these jobs actually ask. The other thing I have come to believe, watching it from both sides now, is that the transition does not happen alone. The CEO and COO at the table I described in the opening had decided, before I walked in, that the incorporation of their feedback mattered both to my growth and to the organization. The leaders who make these transitions possible are the ones who surround themselves with people who are better and brighter than they are. And then they do not stop there. They name the gap before it becomes a pattern, and they stay in the room after the feedback is given. The longer answer to all of this, and the part I am most curious to read, is the half you are about to write.

— David

---

David,

Reading your half, the phrase that kept coming back to me was your idea that clinicians are trained to become “the answer,” while leadership requires us to create the conditions where the best answers can emerge from the group. I think that is exactly right. And I think it explains why so many exceptional CRNAs, and clinicians more broadly, struggle when they first move into administrative leadership. The skill sets overlap far less than people assume.

My own journey from clinical CRNA to founder, business owner, and senior executive has been a slow evolution over more than 20 years. The honest truth is that the evolution is still happening. Daily.

As CRNAs, we talk about being lifelong learners clinically. We accept that mastery requires continuous development of knowledge, judgment, and technical skill. But many clinicians underestimate what the transition into administrative leadership requires, and that underestimation can make the transition far more difficult than it needs to be.

I think of the Dunning-Kruger curve, where early success can feel like mastery just before the floor falls out. Clinicians have lived this phenomenon during training, during early practice, and during the long arc of mastering a craft. We somehow fail to apply the same humility when moving into leadership. We assume that because we were excellent clinically, leadership will come naturally.

It usually does not.

One of the first things I noticed was the loss of the immediate feedback loop we get in clinical anesthesia. As a CRNA, I was used to making a decision and seeing the physiologic response in seconds or minutes. The work is tangible. The feedback is immediate. There is comfort in that. There is certainty in that. There is identity in that.

Leadership is much messier.

The other early lesson, after starting my own company and growing it, was that my personal ability to perform anesthesia became progressively less important to my success as an executive. That sounds strange to say out loud in a profession where clinical excellence is rightly revered, but it is true. The larger the company grew, the more the job became about building systems, developing people, creating alignment, and helping teams solve problems together. Scale is impossible without that network. No founder can be the answer to every problem and have it work.

The move from clinical CRNA to leader is really a move from personal execution to organizational execution. That transition is uncomfortable for clinicians because we were trained and rewarded for being individually excellent. Leadership rewards patience, communication, emotional control, long-term thinking, the ability to simplify complexity, and the ability to create buy-in instead of being correct.

That journey for me was slow, not linear, and not always graceful. I fought it at times. Then the weight of the role landed in a way I could not push back against, and I understood that leadership was not about having all the answers. It was about helping the organization become capable of finding better answers together.

I have watched incredibly smart CRNAs fail in leadership roles because they believed their clinical expertise alone would carry them. Clinical expertise gets you invited into the room. What determines whether you remain effective is your ability to build trust, align people, and translate complexity into action.

Your point about the translator role resonated with me because it may be the core function of clinicians in healthcare leadership. Clinicians often underestimate how little operational, financial, and organizational context exists outside their lane. Executives sometimes underestimate the realities and constraints of clinical care. Someone has to bridge that gap, and clinicians who learn systems thinking and the broader environment are uniquely positioned to do it.

As a COO, I have often translated in the opposite direction of the examples you described. I understand why a facility administrator is focused on subsidy structure, payer mix, staffing efficiency, or contract language. I understand why a CFO worries about labor expense growth or why operations is trying to standardize workflows. But if those realities reach clinicians without context, trust deteriorates quickly.

The clinician hears: “They only care about money.”

What they often do not see is that sustainability is what allows the mission to continue in the first place. Likewise, executives sometimes view clinician concerns as resistance or emotion, when in reality those clinicians are sending signals from the bedside that operators and finance leaders cannot see from conference rooms, spreadsheets, or board decks.

The clinical leaders who become effective are the ones who move fluidly between those worlds without losing credibility in either. That requires humility, because both sides will correct you regularly if you are listening honestly.

Early in my leadership journey, I struggled to build that bridge. Even now, the bridge-building is most of the work. Finding outcomes hospital administrators can support while also advocating for the success and stability of the clinical team is central to operational leadership.

When done well, that bridge creates stability. Stability in staffing. Stability in patient care. Stability in facility relationships. Stability in financial performance.

I have many examples from the early days of YPS Anesthesia where a department of CRNAs and physicians needed support, hospital administration was on a different page, and the department was at risk of fragmenting. The issue was financial in some cases, structural in others, relational or communication-based in others. Learning to find an outcome where everyone could move forward together has been one of the most gratifying parts of leadership, and one of the most important drivers of business success. Many organizations fail not because the clinicians are poor or the administrators unreasonable, but because no one translated between the two.

This is why the transition from clinical practice to administrative leadership requires more than ambition. It requires humility, curiosity, and the discipline to stop proving you are the smartest clinician in the room and start proving you can help the room make better decisions.

The goal is no longer to personally deliver the perfect anesthetic. The goal is to build the teams, systems, and cultures where excellent care happens reliably, repeatedly, at scale.

That is the real transition.

Not from clinician to administrator. From expert doer to builder of people, systems, and trust.

For those willing to make that transition, the impact extends far beyond any single room, any single case, or any single day in practice.

— Tracy

Tracy Young's version of this piece appears on his Substack at tracypyoung.substack.com.

Past the Door’s paid tier opens Monday, June 8. The first paid post lands Friday, June 12. Founder pricing — $6/month or $60/year — runs through July 7.

I sit down with them in the waiting room. I am the anesthesiologist. The surgeon will not be out for another hour, and there are questions the family did not know how to ask the surgical team during the consent conversation earlier. I translate. I draw a small picture on the back of a hospital form showing the new liver in place and the old liver out. I explain the meaning of the numbers on the monitor when the patient gets to the ICU. I tell them what the next twelve hours typically look like and which of those hours are the ones that worry the team most. Their questions slow down, and then they stop. The room is different than it was when I sat down.

Most readers will never sit in that room. They also will never sit in the operating room I just came from, where six clinicians worked through the night while their patient could not see them and his family could not enter. That OR is not the only room those readers cannot see.

There is the boardroom of a large non-profit health system, where the compensation committee approves the executive package against a market study the rest of the organization will never see. There is the executive office a floor below it, where workforce planning runs into the limits of how many nurses and physicians the country is actually graduating each year, and where the conversation either turns into a problem or turns into a plan. There is the credentialing committee, where the existing physicians on staff decide who joins them and where the names available to do the work get fewer every quarter. There is the peer review committee, where a physician’s clinical work is examined by their colleagues behind a closed door, and where the lessons of a hard case become the standard a department is held to. There is the conference room, where a payer and a health system negotiate the unit prices that will quietly determine, eighteen months later, how many nurses are at the bedside on a Tuesday night. There is the C-suite succession meeting where the question of who replaces the CEO when he retires gets decided long before the rest of the organization knows there is a question. There is the M&A meeting where a community hospital becomes a chain asset. There is the regulatory hearing room, where a federal agency writes a rule that will, twelve to eighteen months later, change which procedures can be done in which settings and who gets paid for them.

These rooms are not secret in any movie sense. The decisions made in them are not malicious or hidden. The rooms are simply not open to the people whose work and lives are most directly affected by what happens inside them.

I have spent more than two decades inside both kinds of rooms. The clinical ones, in the operating rooms and the ICU and the holding bay and the recovery unit. The administrative ones, in large health system leadership, and now in my role as Chief Clinical Officer at Essential Anesthesia Management. I am still in both. People sometimes ask why I would leave the bedside for the boardroom, a move some call “becoming a suit.” I have not left. The two are different kinds of work, and they are complementary. On a clinical day, the work is direct and immediate. It is the patient in front of me, the family in the waiting room, the team around the operating table. In the executive rooms, the work is a step removed: the conditions that determine what every team in the system can do at the bedside. I provide patient care a few shifts a month because there is nothing more grounding than an interaction with a patient and family on what is often one of the worst days of their lives. I sit in the executive rooms because the decisions made there determine how many of those interactions are possible, how well the people doing them are supported, and how long the system that makes them possible can keep operating.

This newsletter writes from those rooms.

It does not write about them in the gossip-column sense. It does not name and blame. It does not traffic in the kind of healthcare commentary that depends on outrage to hold a reader’s attention. It writes plainly and specifically about what happens in the rooms most readers do not enter, and why those things matter for the patients, clinicians, and families who live with the downstream effects.

The discipline of this writing is straightforward, and it is worth saying aloud at the start so the reader can hold me to it. I will credit by name the leaders, clinicians, and operators whose work I respect. I will not publicly name and critique colleagues or former employers; that work belongs in private conversation, not in a public forum. I will sit with complexity rather than pretend it does not exist. I will share the strongest counterargument to my position before answering it. If I change my mind on something I have argued for in print, I will say so, and I will explain why. I will not exaggerate for effect. I will not lean on absolute language to compensate for an argument I have not earned. Solid arguments do not need formatting to land well, and I will keep my hand off the bold key as much as I can.

A short preview of where the writing is going next.

I plan to write about the workforce cliff that healthcare is already starting to feel. The story most people hear is about a shortage of interest in clinical careers. The actual problem is closer to the opposite. In many of the relevant training programs, qualified applicants consistently outnumber seats, and the binding constraint is not interest or aptitude. The constraint is clinical training capacity, the number of teaching sites and clinical faculty the country can actually field, and the federal and state policy choices that determine how that capacity is funded and approved. That is a different problem than the one most leaders are solving for, and it has different solutions.

I plan to write about executive compensation in non-profit health systems. There are structural features of the non-profit construct, written into federal tax policy and overseen unevenly at the state level, that make it possible for a senior executive’s total compensation to run five or ten times that of the median nurse at the bedside in the same hospital, and to do so with less public visibility than equivalent compensation would receive in a for-profit setting. I am not arguing the non-profit construct is fundamentally broken. I am arguing the construct has features that allow executive compensation to scale faster than the mission’s reach into the communities the institution was built to serve, and that the same construct supports services for-profit systems will not provide. Both of those things are true. The conversation we are not having is about the features themselves.

I plan to write about leadership development as legacy work. One of the most important tasks of a senior healthcare leader is to develop the next generation of leaders to be better than we are, to think and plan and listen more carefully than we did, and to know we have done the work when those we are developing prove they are better positioned than we are to address the problems of the next decade. We are successful when those we are developing put us out of a job. The reason that line freezes the room is that most leaders are still measuring success by how long they hold their seat, not by who they have ready to take it.

The transplant case ended well. The patient was extubated a few hours after arriving in the ICU. His wife thanked the team while still holding the same paper cup of coffee, and every question she had walked in with had an answer. The room she had sat down in at midnight was a different room when she stood up to leave.

Most of healthcare’s rooms close before that kind of moment can happen in them. The work of this newsletter is to hold the door open long enough for the reader on the other side to see what happened inside, and to walk away understanding it.

The pieces that follow will trust the reader to hold complexity, decline the easy reach for outrage, and arrive at a regular rhythm whether the news cycle is hot or quiet. They will be uneven in topic and consistent in discipline.

If that is the kind of writing you want in your inbox, I am glad you are here.

A free post most weeks, on healthcare leadership, the systems we run, and the policy choices that quietly shape both. A paid post every other week, opening at Week 4, that goes deeper than the free posts can. The occasional argument I would not be able to make if I had not been in the rooms myself. Plain-spoken. Sharp on specifics. Constructive over corrosive.